Drawing for IMMUNIO

USPTO serial 79108495

IMMUNIO

Reviewed by CopyMark Law Group

Reg. 4204233Status 404
Filing date
Status date
Registration date
Sep 11, 2012
Examiner
HELLMAN, ELI J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements in the nature of nutritional additives for medical use; medical nutritional supplements taken by mouth; foodstuffs, dietetic sugar for medical use; nutritionally fortified beverages; foodstuffs for medical use, namely, dietetic sugar; vitamin preparations; mineral food-supplements; pharmaceutical and sanitary preparations for medical use for fighting against viral and bacterial infections and/or improving the effects of vaccinations; pharmaceutical and sanitary preparations for medical use for fighting against respiratory and gastro-intestinal infections; pharmaceutical and sanitary preparations for medical use for stimulating the immune defense; medicines and medical preparations, namely, freeze-dried bacteria used for producing biological preparations for use in treatments in humans for viral, gastro-intestinal and bacterial infections and/or for improving the effects of vaccination; anti-fungal and/or antibiotic preparations; disinfectants for use in the sanitary follow-up of patients suffering from infections; appetite suppressants, mineral enhanced waters for medical purposes; medical preparations for slimming purposes; reducing tea for medical purposes; milk ferments for pharmaceutical purposes; dietary supplements in the nature of non-nutritive edible plant fibers; dietary supplements in the form of gelatin for medical purposes; royal jelly for medical purposes; homeopathic supplements; medicated mouthwashes; medicinal infusions for treating intestinal disorders, vaginal disorders; medicinal plant extracts; vaccines; lactose for medical purposes; extracts of hops for pharmaceutical use; albumen for medical use; starch for dietetic or pharmaceutical use; dietetic sugar, malt, lecithin, yeast for medical use purposes; baby food; pharmaceutical preparations for the treatment of intestinal disorders, vaginal disorders, the aforementioned in the form of wafers, pastils, sachets, hard gelatin capsules, and syrups; medicines for the treatment of intestinal disorders, vaginal disorders, the aforementioned not water soluble and administered in suspension form to be shaken for blending before absorptionSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 9, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 11, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 14, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 12, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 12, 2020INPCINVALIDATION PROCESSED—
Dec 12, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 12, 2019C71TCANCELLED SECTION 71—
Jun 16, 2016ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 25, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 18, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2013FIMPFINAL DISPOSITION PROCESSED—
Dec 11, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 10, 2012GPNXNOTIFICATION PROCESSED BY IB—
Sep 11, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 26, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 6, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 6, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 6, 2012NPUBNOTICE OF PUBLICATION—
May 18, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 16, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 7, 2012ALIEASSIGNED TO LIE—
Apr 27, 2012RFNTREFUSAL PROCESSED BY IB—
Apr 27, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 21, 2012RFRRREFUSAL PROCESSED BY MPU—
Feb 21, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 18, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 17, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2012DOCKASSIGNED TO EXAMINER—
Feb 16, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 9, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance